The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to ...
According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...
The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...
Yesterday the World Health Organization (WHO) said Tanzania has 1 confirmed case of Marburg and 25 suspected cases all from ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near future ...
Oracle on Tuesday released a new set of artificial intelligence agents to help salespeople with a range of tasks around ...
Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...